• Comprehensive Cardiac Insight: Understand your genetic predisposition to coronary heart disease, atrial fibrillation, sudden cardiac arrest, hypertension, and heart failure.
• Diabetes Risk Assessment: Identify genetic risk for Type I and Type II diabetes and underlying obesity factors.
• Medication Safety: Discover how your body metabolizes vital cardiac and metabolic drugs like Warfarin, Clopidogrel, and Metformin.
• Lifestyle Risk Factors: Learn about hereditary traits influencing heart health including nicotine dependence, LDL cholesterol imbalances, and inflammation markers.
• Proactive Prevention: Move from reactive treatments to proactive, life-saving prevention with personalized genomic intelligence.
🧬 Evaluated Across 4 Critical Panels
Heart Health:
Coronary Heart Disease (CAD), Atrial Fibrillation, Sudden Cardiac Arrest, Hypertension, Heart Failure
Endocrine & Metabolism:
Type I Diabetes, Type II Diabetes, Obesity risks
Risk Factors & Lifestyle:
Nicotine Dependence, LDL Cholesterol imbalances, Sleep Depth, Systemic inflammation markers
Medication Response (Pharmacogenomics):
Warfarin, Clopidogrel, Metformin, and more
Microarray or NGS is used to generate data for Cardiomap. The report is generated based on Polygenic Risk Score (PRS) analysis.